Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.2.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Schedule of restricted stock unit activity
     
Outstanding January 1, 2022     350,000  
Granted     35,000  
Vested     (185,000 )
Canceled     (50,000 )
Outstanding June 30, 2022     150,000  
Schedule of stock option activity
                       
    Common Stock Options  
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
  Intrinsic Value  
Outstanding at January 1, 2022     1,964,045     $ 3.33                
Granted     605,704     $ 6.91                
Forfeited     (369,733 )   $ 3.63                
Exercised     (49,769 )   $ 1.00                
Outstanding at June 30, 2022     2,150,247     $ 4.26           $    
Exercisable at June 30, 2022     278,333     $ 1.00       8.91   $ 233,800  
Schedule of stock-based compensation expense
                     
   

Three Months
Ended

June 30,

2022

 

Three Months
Ended

June 30,

2021

 

Six Months
Ended

June 30,

2022

 

Six Months
Ended

June 30,

2021

 
Cost of Goods Sold   $ 55,373   $   $ 277,879   $  
Sales and Marketing     188,529     5,130     461,856     52,856  
Product Development     233,050     101,921     579,194     128,678  
General and Administrative     147,662     96,665     880,850     13,225,060  
Total   $ 624,614   $ 203,716   $ 2,199,779   $ 13,406,594  
Schedule of income statement
     
   

Three Months Ended

June 30,

2021

(as previously reported)

 
Cost of Goods Sold   $  
Sales and Marketing     24,176  
Product Development     50,307  
General and Administrative     13,128,395  
Total   $ 13,202,878